Share to Facebook Share to Twitter Bookmark and Share
Record #: SO2019-1502   
Type: Ordinance Status: Passed
Intro date: 3/13/2019 Current Controlling Legislative Body: Committee on Zoning, Landmarks and Building Standards
Final action: 10/14/2021
Title: Zoning Reclassification Map Nos. 2-H and 4-H at Illinois Medical District - App No. A8728
Sponsors: Burnett, Jr., Walter, Ervin, Jason C.
Topic: ZONING RECLASSIFICATIONS - Map No. 2-H, - ZONING RECLASSIFICATIONS - Map No. 4-H
Attachments: 1. O2019-1502.pdf, 2. SO2019-1502.pdf
FINAL FOR PUBLICATION



ORDINANCE


BE IT ORDAINED BY THE CITY COUNCIL OF THE CITY OF CHICAGO:
SECTION 1. Title 17 of the Municipal Code of Chicago, the Chicago Zoning Ordinance, is hereby amended by changing all of the Institutional Planned Development Number 30 (Council Journal 54046 et al. approved 10/1/97) symbols and indications as shown on Map Numbers 2-H and 4-H in the area bounded by:
the north line of West Congress Parkway; South Ashland Avenue; the alley next south of West 15th Street; South Paulina Street; West 15th Street; South Wood Street; West 14th Street; South Damen Avenue; the north line of the Chicago and Northwestern Railroad right-of-way; and South Oakley Boulevard,

to the designation of C2-5 Motor Vehicle-Related Commercial District.

SECTION 2. Title 17 of the Municipal Code of Chicago, the Chicago Zoning Ordinance, is hereby amended by changing all of the C2-5 Motor Vehicle-Related Commercial District symbols and indications as shown on Map Numbers 2-H and 4-H in the area bounded by:

the north line of West Congress Parkway; South Ashland Avenue; the alley next south of West 15th Street; South Paulina Street; West 15th Street; South Wood Street; West 14th Street; South Damen Avenue; the north line of the Chicago and Northwestern Railroad right-of-way; and South Oakley Boulevard,

to the designation of Institutional Planned Development 30, as amended.

SECTION 3. This ordinance shall be in force and effect from and after its passage and due publication.
FINAL FOR PUBLICATION
The area delineated herein as Institutional Planned Development Number 30, as amended (the "PD") consists of approximately sixteen million two hundred fifty-two thousand and sixty-seven (16,252,067) net square feet or three hundred seventy-three and one-tenth (373.10) net acres of property, which is depicted on the attached Planned Development Boundary Map (the "Property") and is owned or controlled by the Illinois Medical District Commission (the "Applicant"), established pursuantto the Illinois Medical District Act, 70 ILCS 915/0.01, etseq. (the "Act"). This comprehensive amendment to Institutional Planned Development Number 30 is an appropriate zoning ordinance for the area within the Illinois Medical District boundaries and is consistent with the zoning and uses of property surrounding the Property under the Chicago Zoning Ordinance ("CZO").
The requirements, obligations, and conditions contained within this PD and, subject to the provisions herein, the rights granted by this PD shall be binding upon and inure to the benefit of the Applicant, to any legal titleholder or ground lessor of land within the PD and to their successors and assigns. Pursuant to the requirements of Section 17-8-0400 of the CZO, at the time of any application for an amendment, modification, or change to this PD (administrative, legislative, or otherwise), the Property in this PD shall be under single ownership or under single designated control. Except as provided herein, single designated control shall mean that only the Applicant may apply for an amendment or other change to this PD (administrative, legislative, or otherwise) and that only the Applicant may apply to or enter into an agreement with the Department of Planning and Development ("DPD"), the Department of Transportation ("CDOT"), or any other City department. Applicant shall have authority to authorize any property owner, ground lessor, or developer to conduct tasks on Applicant's behalf (a "Designated Developer"); any such designation must be in writing and filed with DPD. Before a Designated Developer enters an agreement with CDOT or any other City department, a copy of the designation must be filed with DPD and CDOT or the applicable department. Provided, however, that in instances where the property which is the subject of the request is owned by any federal, state, or local unit of government ("Unit of Government"), then said application or request for modifications or agreement with a Department may be made by that unit of government with written notice provided to the Applicant at the time ofthe request or agreement.





ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION


3. All applicable official reviews, approvals, or permits are required to be obtained by the Applicant, a Designated Developer, or Unit of Government. Any dedication or vacation of streets or alleys or grants of easements or any adjustment of the right-of-way shall require a separate submittal to CDOT by the Applicant, a Designated Developer, or a Unit of Government. Any request for grants of privilege or any items encroaching on the public way shall be in compliance with this PD. Ingress or egress shall be pursuant to this PD and may be subject to the review and approval of DPD and CDOT. Closure of all or any public street or alley during demolition or construction shall be subject to the review and approval of CDOT. All work proposed in the public way must be designed and constructed in accordance with the CDOT Construction Standards for Work in the Public Way and Street and Site Plan Design Guidelines and the Municipal Code of Chicago ("MCC") 10-20.

Pursuant to a negotiated and executed Perimeter Restoration Agreement ("Agreement") by and between CDOT's Division of Infrastructure Management and the Applicant, a Designated Developer, or a Unit of Government, improvements and restoration of all public ways adjacent to redeveloped properties shall be required. Improvements and restoration may include, but not be limited to, the following, as shall be reviewed and determined by CDOT's Division of Infrastructure Management:

Full width of streets Full width of alleys Curb and gutter Pavement markings Sidewalks
ADA crosswalk ramps Parkway and landscaping
The Agreement must be executed prior to any CDOT and PD Part II Approval. The Agreement shall reflect that all work must comply with current CDOT Rules and Regulations and must be designed and constructed in accordance with CDOT's Construction Standards for Work in the Public Way and in compliance with MCC Chapter 10-20. Design of said improvements should follow CDOT's Rules and Regulations for Construction in the Public Way as well as The Street and Site Plan Design Guidelines. Any variation in scope or design of public way improvements and restoration must be approved by CDOT.




ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION
This Plan of Development consists of seventeen (17) Statements along with:

Bulk Regulations Table Parking Ratio Table Minimum Lot Area/Unit Table Planned Development Boundary Map District Sub-Areas Map Sub-Area Maps
In any instance where a provision of this PD conflicts with the Chicago Building Code, the Building Code shall control. This PD conforms to the intent and purpose of the CZO and all requirements thereto and satisfies the established criteria for approval as a planned development. In case of a conflict between the terms of this PD and the CZO, this PD shall control.
Except as provided in this Statement, all uses allowed by the CZO within the C2, Motor Vehicle-Related Commercial District, shall be permitted on the Property, subject to Applicant's approval of placement of uses by Sub-Area in conformance with the Master Plan and Design Guidelines most recently approved by the Illinois Medical District Commission. Applicant shall provide written notice to DPD of any amendments to the Master Plan and Design Guidelines.

No use which requires a Special Use Permit before being established or operated within a planned development may be established or operated within this PD except upon approval by the Zoning Board of Appeals pursuant to the standards under Section 17-13-09000 ofthe CZO.
On-Premise signs and temporary signs, such as construction and marketing signs, shall be permitted within this PD, subject to the review and approval of the Applicant and DPD. Off-Premise signs, other than Applicant's kiosk program signs, are prohibited within the boundary of this PD unless specifically approved by the Applicant and DPD.
For purposes of height measurement, the definitions in the CZO shall apply. The height of any building shall also be subject to height limitations, if any, established by the Federal Aviation Administration. The height of all new buildings within Sub-Area 5A and 5B shall be designed and developed in conformance with the height limitatons of the RT 3.5, Residential Two-Flat, Townhouse and Multi-Unit District Section 17-2-0311-A ofthe CZO and in general conformance with the Master Plan and Design Guidelines.



ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION
The maximum permitted floor area ratio (FAR) for the Property shall be in accordance with the attached Bulk Regulations Table. For the purpose of FAR calculations and measurements, the definitions in the CZO shall apply. The permitted FAR identified in the Bulk Regulations Table has been determined using a net site area of 16,252,067 square feet and a base FAR of 3.19.
Upon review and determination for Part II review, pursuant to Section 17-13-0610 ofthe CZO, a Part II review fee shall be assessed by DPD. The fee, as determined by staff at the time, is final and binding on the Applicant, a Designated Developer, or Unit of Government and must be paid to the Department of Revenue prior to the issuance of any Part II review approval.
All development, including but not limited to renovations of existing buildings and redevelopment or repurposing of vacant land, shall be designed and developed in substantial conformance with the most-recently approved Master Plan and Design Guidelines approved by the Illinois Medical District Commission, the Landscape Ordinance, and Section 17-13-0800 of the CZO. Final landscape plan review and approval shall be conducted by DPD. In the event of a conflict between the provisions of this PD and those ofthe Master Plan, the provisions of this PD shall govern.

Maximum and minimum parking requirements shall be determined as part of Site Plan Approval as provided in this Statement 10 pursuant to the attached Parking Ratio Table. Development sites meeting the eligibility of a Transit-Served Location ("TSL") shall qualify for reductions in parking requirements in accordance with Section 17-10-0102-B ofthe CZO. A development site may be eligible for further parking reductions than those permitted for TSL sites, subject to approval by the Applicant, DPD, and CDOT. Accessory parking lots and structures may serve to satisfy required parking for multiple uses within the PD, subject to the review and approval of the Applicant and CDOT and DPD with written notice and copies of shared parking agreements delivered to CDOT and DPD. Accessory and non-accessory parking facilities may be located anywhere within the PD and used on a shared basis to satisfy parking requirements subject to the review and approval of the Applicant and CDOT and DPD, provided that such locations are consistent with the provisions of the Master Plan and a traffic and parking study, to be completed for any such proposed accessory and non-accessory parking facility and submitted to CDOT and DPD.



ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION


For redevelopment of or new building construction on any property within this PD other than alterations to existing buildings that do not increase their height or floor area ratio or alter their footprint or existing site conditions, the Applicant, a Designated Developer, or a Unit of Government must secure Site Plan Approval following the procedures of Section 17-13-0800 of the CZO prior to approval of Part II review pursuant to Section 17-13-0610 of the CZO.

Prior to Part II review approval pursuant to Section 17-13-0610 of the CZO for any property, the Applicant, a Designated Developer, or a Unit of Government shall submit a site plan, landscape plan and building elevations for the review and approval by DPD. Review and approval by DPD are intended to assure that specific development components substantially conform with this PD and to assist the City in monitoring ongoing development. Sub-Area Site Plan Approval submittals pursuant to Section 17-13-0800 of the CZO need only include that property for which approval is being sought. If the Applicant, a Designated Developer, or a Unit of Government is seeking approval for a site that is less than an entire Sub-Area, the application shall include a site plan that shows all land between the site and the nearest public Rights-of-Way or the boundary of the nearest Sub-Area. The site plan provided shall include all planned street Rights-of-Way with dimensions.

If Site Plan Approval is required, no Part II Approval for any portion ofthe Property shall be granted until Site Plan Approval has been granted. Following approval by DPD, the approved Sub-Area Site Plan Approval submittals, supporting data and materials shall be made part of the main file and shall be deemed to be an integral part of the PD.

After approval of the Sub-Area Site Plan, changes or modifications may be made pursuant to the provisions of Statement 10. In the event of any inconsistency between approved plans and the terms ofthe PD, the terms ofthe PD shall govern. Any Sub-Area Site Plan Approval submittals shall, at a minimum, provide the following information:

Fully-dimensioned site plan (including a footprint of the proposed improvements) Fully-dimensioned building elevations Fully-dimensioned landscape plan(s)
Statistical information applicable to the subject Sub-Area, including floor area, the applicable floor area ratio, uses to be established, building heights and setbacks


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION


Sub-Area Site Plan Approval submittals shall include all other information necessary to illustrate substantial conformance to the PD.

Following approval by DPD, the Site Plan Approval, supporting data and materials shall be made part of the main file and shall be deemed to be an integral part of the PD.

Any interim reviews associated with Site Plan review or Part II review are conditional until final Part II Approval.
The Applicant, a Designated Developer, or a Unit of Government shall comply with Rules and Regulations for the Maintenance of Stockpiles promulgated by the Commissioners of the Departments of Streets and Sanitation, Fleet and Facility Management, and Buildings, under Section 13-32-085 ofthe MCC, or any other provision ofthe MCC.
The terms and conditions of development under this PD may be modified administratively, pursuant to Section 17-13-0611-A of the CZO, by the Zoning Administrator upon the application for such a modification by the Applicant, a Designated Developer, or Unit of Government.
The Applicant acknowledges that it is in the public interest to design, construct, and maintain newly developed projects in a manner that promotes, enables, and maximizes universal access throughout the Property. Plans for all new buildings shall be reviewed and approved by the Mayor's Office for People with Disabilities to ensure compliance with all applicable laws and regulations related to access for persons with disabilities.
The Applicant acknowledges that it is in the public interest to design, construct, renovate and maintain all buildings in a manner that provides healthier indoor environments, reduces operating costs, and conserves energy and natural resources. Projects subject to Site Plan Approval shall obtain the number of points necessary to meet the requirements of the Chicago Sustainable Development Policy in effect at the time the Part II review process is initiated for each improvement that is subject to the Sustainable Development Policy and must provide documentation verifying compliance.






ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION
The Applicant acknowledges that it is the policy of the City to maximize opportunities for Minority and Women-owned Business Enterprises ("MAA/BEs") and city residents to compete for contracts and jobs on construction projects approved through the PD process. To assist the City in promoting and tracking such MAA/BE and city resident participation, the Applicant, a Designated Developer, or a Unit of Government shall provide information at three points in the City approval process for any project requiring Site Plan Approval. First, as part of an application for Site Plan Approval, a MAA/BE Participation Proposal must be submitted. The MAA/BE Participation Proposal must state goals for participation of certified MAA/BE firms in the design, engineering, and construction of the project and of city residents in the construction work. The City encourages goals of: (i) 26% MBE and 6% WBE participation (measured against the total construction budget for the project or any phase thereof); and (ii) 50% city resident hiring (measured against the total construction work hours for the project or any phase thereof). The MAA/BE Participation Proposal must include a description of the proposed outreach plan designed to inform M/WBEs and city residents of job and contracting opportunities. Second, at the time of submission for Part II review for the project or any phase thereof, the following must be submitted to DPD: (a) updates (if any) to the proposed outreach plan; (b) a description of the outreach efforts and evidence of such outreach, including, without limitation, copies of certified letters to MAA/BE contractor associations and the ward office of the alderman in which the project is located and receipts thereof; (c) responses to the outreach efforts; and (d) updates (if any) to the MAA/BE and city resident participation goals. Third, prior to issuance of a Certificate of Occupancy for the project or any phase thereof, DPD must receive evidence of the actual level of MAA/BE and city resident participation in the project or any phase thereof, and evidence of such participation. In addition to the foregoing, DPD may request such additional information as the department determines may be necessary or useful in evaluating the extent to which MAA/BEs and city residents are informed of and utilized in planned development projects. All such information shall be provided in a form acceptable to the Zoning Administrator. DPD shall report the data it collects regarding projected and actual employment of MAA/BEs and city residents in planned development projects twice yearly to the Chicago Plan Commission and annually to the Chicago City Council and the Mayor.
The Applicant acknowledges and agrees that the rezoning of the Property from Institutional Planned Development 30, as amended (having an underlying zoning of C1-2 Neighborhood Commercial District) to C2-5 Motor Vehicle-Related Commercial District and then


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION


to this Institutional Planned Development 30, as amended, is an "entitlement" within the meaning of Section 2-44-085 of the MCC (the "2021 ARO"). Applicant agrees that all "residential developments" or "residential projects" (as such terms are defined in the 2021 ARO) within the PD will be subject to the 2021 ARO.

17. The Applicant acknowledges that it is in the public interest to ensure that adequate open space and recreational facilities are provided to serve new residential developments. All open spaces developed for use by the public must be in compliance with the Open Space Impact Fee Administrative Regulations and Procedures promulgated by the Commissioner of DPD, pursuant to Section 16-18-110 of the MCC. Impact Fees shall not be required for projects wholly owned and developed solely by Applicant or a Unit of Government.



































ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 26, 2021

FINAL FOR PUBLICATION
Bulk Regulations Table

Sub-Area Net Site Area (SF) Net Site Area (Acres) Maximum Floor-Area-Ratio
1A 1,303,765 29.93 3.00
IB 454,446 10.43 3.50
2A 1,173,168 26.93 4.00
2B 189,358 4.35 4.00
3A 1,205,271 27.67 4.00
3B 151,854 3.49 2.20 |109|152,226 3.49 1.50
5A 534,715 12.28 1.20
5B 113,585 2.61 1.20 |109|211,661 4.86 2.20 |109|615,293 14.13 3.25 |109|3,615,926 83.01 3.50 |10 9|477,067 10.95 3.00
10 515,242 11.83 3.00
11 906,543 20.81 3.50
12 698,982 16.05 3.20
13 419,855 9.64 2.60
14 148,613 3.41 2.20
15 1,166,243 26.77 3.20
16 1,210,113 27.78 3.20
17 158,308 3.63 2.20
18 829,833 19.05 2.20
Totals 16,252,067 373.10 3.19









ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021

FINAL FOR PUBLICATION
Parking Ratio Table

Subarea Parking Minimum* Parking Maximum*
1A C2-5 C2-3
IB C2-5 C2-3
2A C2-5 C2-3
2B C2-5 C2-3
3A C2-5 C2-3
3B C2-3 C2-2 |109|C2-3 C2-2
5A C2-3 C2-2
5B C2-3 C2-2 |109|C2-3 C2-2 |109|C2-3 C2-2 |109|C2-5 C2-3 |10 9|C2-5 C2-3
10 C2-5 C2-3
11 C2-5 C2-3
12 C2-5 C2-3
13 C2-3 C2-2
14 C2-3 C2-2
15 C2-5 C2-3
16 C2-5 C2-3
17 C2-3 C2-2
18 C2-3 C2-2


""Subject to the off-street parking ratios for the specified zoning district in the CZO.







ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021

FINAL FOR PUBLICATION
Minimum Lot Area/Unit (MLA/U) Table**

Sub-Area Per Dwelling Unit Per Efficiency Unit Per SRO Unit
1A* 400 300 200
IB 200 135 100
2A 200 135 100
2B 200 135 100
3A 200 135 100
3B* 1,000 700 700
4* 1,000 700 NA
5A* 1,250 700 NA
5B* 1,250 700 NA
6* 1,000 700 700 |109|200 135 100 |109|200 135 100
g* 400 300 200
10* 400 300 200
11 200 135 100
12 200 135 100
13* 400 300 200
14* 1,000 700 700
15 200 135 100
16 200 135 100
17* 1,000 700 700
18* 1,000 700 700
*Within the Sub-Area, all projects located within 1,320 feet of a CTA or METRA rail station entrance or a CTA bus line corridor roadway segment listed in Table 17-10-0102-B.l.b of the CZO or within 2,640 feet of a CTA or METRA rail station entrance or a CTA bus line corridor roadway segment listed in Table 17-10-0102-B.l.b of the CZO when the subject building is located along a pedestrian street or pedestrian retail street, and which provide no more than one parking space per dwelling unit, are eligible to use the reduced lot area per unit standards for TSL eligible sites in accordance with Section 17-3-0402-B ofthe CZO.
** The limits on the ratio of efficiency units to dwelling units as per Section 17-3-0410-A of the CZO do not apply to transit-served developments within 660 feet of a CTA or METRA rail station entrance or a CTA bus line corridor roadway segment listed in Table 17-10-0102-B.l.b ofthe CZO.

ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021
FINAL FOR PUBLICATION


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021

FINAL FOR PUBLICATION

DISTRICT SUB-AREAS MAP
ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021































¦¦¦¦¦x
FINAL FOR PUBLICATION
ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021










Q Z <
<
<
LU
a. <
If)






























<|1010|^ >¦
o to
£= D
CD O
O CO







I
I I


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021
FINAL FOR PUBLICATION
co
Q Z <
<
in
co <
LU
< i
CO
z>
CO

ED
1J
T^i ¦ n n n: nnrrrr
Bin flQroMQqi.wDf
Inn n i-T-i nr-irncJm nt


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021








m
in
Q Z <


10
<
LU
et < clS
CO

























I
I I





























0> <

Q) O
O c
CD O
Q CO


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021
FINAL FOR PUBLICATION
o
tH
Q Z <

CO
<
LU
DC
< ¦
CO => CO

rrmn „ ^ n 5mn n nPH=i
Ha CH 0 tun—nnrjrotr

3g ? CDEIOQ
Hod














































I I














































o
LO CNI
ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021

FINAL FOR PUBLICATION















































00 CO






























< .A


cp o
Q CD











I I
ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021


ILLINOIS MEDICAL DISTRICT
INSTITUTIONAL PLANNED DEVELOPMENT 30, AS AMENDED INTRODUCTION DATE: MARCH 13, 2019 PLAN COMMISSION DATE: AUGUST 19, 2021

DEPARTMENT OF PLANNING AND DEVELOPMENT CITY OF CHICAGO


MEMORANDUM

Alderman Thomas Tunney
Chairman, City Council Committee on Zoning

From:
Maurice D. Cox J Chicago Plan Commission

Date: August 26, 2021

Re: Proposed Planned Development for the property bounded by Congress Parkway to the north; South Ashland Avenue to the east; the alley next south of West 15th Street, South Paulina Street, west 15th Street, South Wood Street, West 14th Street, South Damen Avenue and the north line of the Chicago and Northwestern Railroad right-of-way to the south; and South Oakley Boulevard to the west.


On August 26, 2021, the Chicago Plan Commission recommended approval of the Zoning Map Amendment submitted by, Alderman Walter Burnett of the 27th Ward and Alderman Jason Ervin ofthe 28th Ward. A copy of the proposed Zoning Map Amendment is attached. I would very much appreciate your assistance in having this introduced at the next possible City Council Committee on Zoning.

Also enclosed is a copy ofthe staff report to the Plan Commission which includes the Department of Planning and Development, Bureau of Zoning and Land Use recommendation and a copy ofthe resolution. If you have any questions in this regard, please do not hesitate to contact me at 744-9476


Cc: Steve Valenziano
PD Master File (Original PD, copy of memo)









121 NORTH LASALLE STREET, ROOM 1000, CHICAGO, ILLINOIS 60602